Page last updated: 2024-08-05 13:32:48

sialotriaosylceramide

A ganglioside in which the oligosaccharide portion is composed of a trisaccharide, to which one or more sialic acid residues are attached.

ChEBI ID: 36541

Members (3)

MemberDefinitionRole
g(m2) gangliosideA sialotriaosylceramide that is N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-acylsphingosine in which the acyl group on the sphingosine nitrogen is octadecanoyl. A constituent of natural ganglioside GM2.ganglioside GM2 (18:0)
g(m3) gangliosideA sialotriaosylceramide consisting of beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc attached to the primary hydroxy function of ceramide(d18:1/24:1(15Z)).3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:1(15Z)).html>alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:1(15Z)); ganglioside GM3
n-glycolylneuraminyllactosylceramideA sialotriaosylceramide in which the triaosyl group is 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl attached to the primary hydroxy function of ceramide. A tumour antigen found in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but not usually detected in normal human cells.N-glycolylneuraminyllactosylceramide

Research

Studies (1,612)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990392 (24.32)18.7374
1990's468 (29.03)18.2507
2000's403 (25.00)29.6817
2010's275 (17.06)24.3611
2020's74 (4.59)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials35 (1.95%)5.53%
Reviews118 (6.57%)6.00%
Case Studies89 (4.96%)4.05%
Observational1 (0.06%)0.25%
Other1,552 (86.46%)84.16%